Baculoviral IAP Repeat-Containing 7 (BIRC7) (Middle Region) Peptid
BIRC7
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BIRC7 Produkte
- BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-BIRC7 antibody (Catalog #: AVARP02033_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
- Synonyme
- KIAP Peptide, LIVIN Peptide, ML-IAP Peptide, MLIAP Peptide, RNF50 Peptide, EIAP/XLX Peptide, XLX Peptide, kiap Peptide, livin Peptide, ml-iap Peptide, mliap Peptide, rnf50 Peptide, xEIAP Peptide, RGD1562883 Peptide, zgc:165605 Peptide, E130019N06 Peptide, Livin Peptide, birc7 Peptide, bird7a Peptide, xEIAP/XLX Peptide, xlx Peptide, EIAP/XLX-B Peptide, birc7b Peptide, baculoviral IAP repeat containing 7 Peptide, baculoviral IAP repeat-containing 7 Peptide, baculoviral IAP repeat-containing 7 (livin) Peptide, baculoviral IAP repeat containing 7 S homeolog Peptide, baculoviral IAP repeat containing 7 L homeolog Peptide, BIRC7 Peptide, birc7 Peptide, Birc7 Peptide, birc7.S Peptide, birc7.L Peptide
- Hintergrund
-
BIRC7 protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits caspase-3 and proteolytic activation of pro-caspase-9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis.The protein encoded by this gene is a member of the family of inhibitor of apoptosis proteins (IAP) and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. The BIR domain is essential for inhibitory activity and interacts with caspases, while the RING finger domain sometimes enhances antiapoptotic activity but does not inhibit apoptosis alone. Two transcript variants encoding different isoforms have been found for this gene. The two isoforms have different antiapoptotic properties, with isoform alpha protecting cells from apoptosis induced by staurosporine and isoform b protecting cells from apoptosis induced by etoposide.
Alias Symbols: KIAP, LIVIN, ML-IAP, MLIAP, RNF50
Protein Interaction Partner: CASP3,CASP7,CASP9,DIABLO,HTRA2,CASP3,CASP7,CASP9,XAF1
Protein Size: 298 - Molekulargewicht
- 33 kDa
- Gen-ID
- 79444
- NCBI Accession
- NM_139317, NP_647478
- UniProt
- Q96CA5
-
Sie sind hier:
